Fri. 10 May 2024, 7:03am ET
Benzinga
Earnings, Earnings Misses, News
Humacyte (NASDAQ:HUMA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.22) by 31.82 percent. This is a 19.44 percent increase over losses of $(0.36) per share from the same period last year.